Frontiers in Neuroscience, 2023 · DOI: 10.3389/fnins.2023.1211066 · Published: May 31, 2023
Spinal cord injury (SCI) is a central nervous system disease often caused by accidents, leading to long-term adverse effects. Treatment focuses on improving the microenvironment at the injury site and reconstructing axons. Hydrogels, with their biocompatibility and adjustability, can fill pathological defects and mimic the natural extracellular matrix for cell colonization and axon extension. Composite hydrogel scaffolds, enhanced with different materials, can further improve performance, making them useful in SCI treatment.
Hydrogels provide structural support and promote axonal growth, facilitating nerve regeneration in damaged spinal cords.
Smart hydrogels enable controlled and localized release of therapeutic agents, maximizing efficacy and minimizing side effects.
Clinical trials show that hydrogel-based therapies, especially when combined with cells or growth factors, can improve sensory and motor functions in SCI patients.